Skip to content

Net Income at other companies

IAR
Integra LifeSciencesIART
-$4.62M+81.7%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$9.55M-58.5%
iRadimed logo
iRadimedIRMD
$5.82M+24.1%
Teladoc Health logo
Teladoc HealthTDOC
-$63.84M+31.4%
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
-$34.17M-57.0%
Cerence Inc. logo
Cerence Inc.CRNC
$1.67M-92.3%

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
Operating cash flow-$19.3M-69.2%
CapEx$125.0K-15.5%
Free cash flow-$19.4M-68.1%

Valuation

See full
Market cap$748.61M+15.6%
Enterprise value$725.47M+40.7%
P/S7.9×-1.2×

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Debt / equity0.2×0.0×
Current ratio10.4×-6.9×

Where this comes from

Reported directly by CeriBell, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s net income?
CeriBell, Inc. (CBLL) reported net income of -$19.74M in Q1 2026.
How has CeriBell, Inc.'s net income changed year-over-year?
CeriBell, Inc.'s net income decreased by 54.5% year-over-year, from -$12.78M to -$19.74M.
What is the long-term trend for CeriBell, Inc.'s net income?
Over 2 years (2023 to 2025), CeriBell, Inc.'s net income has grown at a 34.6% compound annual growth rate (CAGR), from -$29.46M to -$53.41M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.